CNS Response Elects David B. Jones of SAIL Venture Partners as New Board Chair

ALISO VIEJO, CA--(Marketwire - June 03, 2011) - CNS Response, Inc. (OTCBB: CNSO) announced that David B. Jones has been elected chairman of the board. Jones is a senior advisory partner at SAIL Venture Partners, with offices in New York City, Irvine, Calif., and Arlington, Va. He has served on the CNS Response Board of Directors since 2006.

“Dave and SAIL Venture Partners have been ardent supporters and advocates for CNS Response,” said CNS Response CEO George Carpenter. “Dave’s experience working with dynamic, growing companies will provide additional benefit in this new Board role.”

CNS Response provides medical professionals with information correlating medication response for patients being treated for mental disorders. The company recently launched the Psychiatric EEG Evaluation Registry, or PEER Online™, a new registry and reporting platform, which provides reference data and analytic tools for clinicians and researchers.

Finding the right medication for an individual patient suffering from mental health issues is one of the biggest challenges in health care. While treatment for mental health disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for a mental disorder.

Prior to joining SAIL Venture Partners, Jones served as chairman and CEO of Dartron, Inc., a computer accessories manufacturer from 1997 to 2003. From 1985 to 1997, he was a general partner of InterVen Partners, a venture capital firm with offices in Southern California and Portland, Oregon. From 1979 to 1985, he was president and CEO of First Interstate Capital, Inc., the venture capital affiliate of First Interstate Bancorp. He is a former chairman of the National Association of Small Business Investment Companies.

Jones is also a director of M2 Renewables, Inc. He is a graduate of Dartmouth College and holds a master’s of business administration and law degrees from the University of Southern California. He resides in Irvine, Calif.

About CNS Response
CNS Response provides reference data and analytic tools for clinicians and researchers through the Psychiatric EEG Evaluation Registry, or PEER Online™, a new registry and reporting platform. The registry builds on the company’s original physician-developed database called Referenced-EEG® (rEEG®). Developed with clinical data supplied by physicians, PEER Online serves as a platform for medical professionals to exchange treatment outcome data referenced to objective neurophysiology data from EEG. Physicians using this information have consistently reported reduction in their use of trial and error pharmacotherapy. To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.cnsresponse.com. Medical professionals interested in learning more can contact CNS Response at PEERinfo@cnsresponse.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements involve risks and uncertainties as set forth in the Company’s filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

Digg this Bookmark with del.icio.us Add to Newsvine

Technorati: mental disorder Psychiatric EEG evaluation medication therapies PEER Online cloud computing